Cannabinoids Data Microdosing 
LifeCannMD
MAY 27, 2025
” I completely understand this concern, and that’s exactly why I’m passionate about educating patients about microdosing cannabis. Three months later, after starting with microdosing marijuana , she’s managing her pain effectively while maintaining complete clarity during her teaching day.
Cannabis Law Report
DECEMBER 2, 2021
The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. THC is a naturally occurring cannabinoid produced by the cannabis plant. million individuals in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JULY 3, 2023
Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it.
CannaMD
OCTOBER 7, 2019
In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. While scientists are still searching for a definitive explanation, researchers with Cannabis and Cannabinoid Research have an interesting theory. Both cannabinoids act via CB1 and CB2 receptors.
Marijuana Packaging
OCTOBER 4, 2018
Microdosing can provide a bit of a safety net if the experience is different than we had imagined but this still doesn’t give us control over the actual direction of the effects. New Frontier Data, for example, calls what we’ve done Cannabis 2.0.” Cannabis 2.0”? One to One. So how do they manage to pinpoint these intended effects?
The Cannigma
FEBRUARY 3, 2022
We find out how women and other estrogen-predominant people react differently to cannabis than men and those with more testosterone, and why microdosing is far more effective for the former. That’s always the struggle we have when people want data and research and medical research to establish exactly how something works.
Cannabis Law Report
JUNE 4, 2021
Paul is the author of the book Microdosing Psychedelics: A Practical Guide to Upgrade Your Life and the founder and CEO of Third Wave and co-founder of Synthesis. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space. in/ronanlevy/. The Third Wave.
Expert insights. Personalized for you.
52 
Let's personalize your content